Dr. Martens (LON:DOCS) Insider Purchases £150.80 in Stock

Dr. Martens plc (LON:DOCS) insider Giles Wilson purchased 232 shares of the business’s stock in a transaction dated Tuesday, April 14th. The shares were acquired at an average price of GBX 65 per share, with a total value of £150.80.

Giles Wilson also recently made the following trade(s):

• On Wednesday, February 11th, Giles Wilson purchased 219 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 69 per share, with a total value of £151.11.

Dr. Martens Stock Up 3.9%

Shares of DOCS stock opened at GBX 69.90 on Friday. Dr. Martens plc has a 12 month low of GBX 51.05 and a 12 month high of GBX 100.87. The firm has a market cap of £675.75 million, a PE ratio of 41.12, a price-to-earnings-growth ratio of 6.40 and a beta of 0.24. The stock has a 50 day moving average of GBX 65.57 and a 200-day moving average of GBX 75.52. The company has a quick ratio of 1.13, a current ratio of 2.18 and a debt-to-equity ratio of 120.66.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Berenberg Bank restated a “buy” rating on shares of Dr. Martens in a research note on Tuesday, January 27th. Royal Bank Of Canada restated a “sector perform” rating on shares of Dr. Martens in a research note on Tuesday, February 3rd. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Dr. Martens has a consensus rating of “Moderate Buy” and an average target price of GBX 6,000.

Dr. Martens Company Profile

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally
produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical
movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over
60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and
wholesale channels, and in addition to its world-renowned “1460” boot its product segments span shoes including the
1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and
accessories.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.